VSV-FL+(2) VSV Plasmid Expression Vector

The plasmid pVSV-FL+(2) encodes the antigenomic-sense (or positive-sense) RNA of vesicular stomatitis virus (VSV) expressed from the bacteriophage T7 promoter in pBS, which has been further modified to contain the hepatitis delta ribozyme used to generate a precise 3’ end of the VSV antigenomic RNA and a T7 terminator sequence cloned between the SacII and SacI restriction sites in pBS-SK+ [1, 2]. The reverse genetics method used to recover recombinant VSV (rVSV) from plasmids involves the transfection of vaccinia-T7 infected cells with 4 different plasmids; one that express the rVSV antigenome (pVSV-FL+(2)) and 3 other that express the VSV N, P, and L proteins, the cDNAs of which are also under control of T7 promoters.

It is the responsibility of the principal investigator to seek Institutional Biosafety Safety Committee approval for recombinant DNA, transgenic animal or infectious agent use within their laboratory spaces and maintain an Institutional Biosafety Safety Committee approval during the time period these materials are used.

From the laboratory of Michael A. Whitt, Ph.D., University of Tennessee.

 

Catalog Number Product DataSheet Size AVAILABILITY Price Qty
EH1001
pVSV-FL+(2) VSV Plasmid Expression Vector
100uL (100ng/uL) In stock
Regular Price:$675.00
On Sale:
EH1002
VSV-FL+(2) VSV Plasmid Expression Vector System
w/ set of Helper Plasmids (VSV-N, VSV-P, VSV-L, VSV-G) In stock
Regular Price:$910.00
On Sale:
Specifications

Product Type: Plasmid
Alternative Name(s): antigenomic-sense (or positive-sense) RNA of vesicular stomatitis virus (VSV)
Gene/insert name: VSV-9.1(+)
Antibiotic Resistance: Ampicillin or Kanamycin (please see vial label and packing slip)
Fusion Tag(s): none
Concentration: 100uL (100ng/uL)
Grow in E. coli at 37 C: Yes
Cloning Site 5': 5' VSV sequence joined directly to T7 promoter
Cloning Site 3': 3' VSV sequence joined directly to HDV ribozyme
Insert Size: 11,161 bp
Vector Backbone and Size: pBS-SK-ΦT, 3105 bp
High or low copy: High
Comments: For suggested protocol, see: Whitt, MA, J. Virol. Methods, 2010. 169(2): p. 365-74.
Shipped: Ambient temperature, spotted on filter paper

Data

VSV recovery requires BHK-21 cells and T7 supplied by vaccinia virus infection.

Provider
From the laboratory of Michael A. Whitt, Ph.D., University of Tennessee.
References
  1. Lawson, N.D., et al., Recombinant vesicular stomatitis viruses from DNA. Proc.Natl.Acad.Sci.(USA), 1995. 92(10): p. 4477-4481.
  2. Stillman, E.A., J.K. Rose, and M.A. Whitt, Replication and amplification of novel vesicular stomatitis virus minigenomes encoding viral structural proteins. J. Virol., 1995. 69: p. 2946-2953.
  3. Yahalom-Ronen Y, Tamir H, Melamed S, Politi B, Shifman O, Achdout H, Vitner EB, Israeli O, Milrot E, Stein D, Cohen-Gihon I, Lazar S, Gutman H, Glinert I, Cherry L, Vagima Y, Lazar S, Weiss S, Ben-Shmuel A, Avraham R, Puni R, Lupu E, Bar-David E, Sittner A, Erez N, Zichel R, Mamroud E, Mazor O, Levy H, Laskar O, Yitzhaki S, Shapira SC, Zvi A, Beth-Din A, Paran N, Israely T. A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge. Nat Commun. 2020 Dec 16;11(1):6402. View article 

If you publish research with this product, please let us know so we can cite your paper.

Loading...